Biolog-id to go public via a SPAC merger with Genesis Growth Tech Acquisition in a $312m.

Biolog-id, a developer of digital health solutions, agreed to go public via a SPAC merger with Genesis Growth Tech Acquisition in a $312m. “Genesis believes that Biolog-id’s proven technology, combined with the clear demand in the digital health space, makes this an attractive investment for our shareholders. We are pleased and proud to partner up with Biolog-id’s leadership team on their mission to optimize the manufacturing, distribution, and utilization of sensitive health products. We are excited about the significant operational, clinical, and financial benefits for patients, providers, payors, and other elements of the healthcare supply chain," Eyal Perez, Genesis Growth Tech Acquisition Chairman and CEO.